Company Profile

Sartorius Stedim Biotech S.A. (OTC: SRTOY)
2:14 PM UTC, 07/02/24
Last: $15.80 Change: +0.00 %Change: +0.00% Volume: 720
Detailed Quote
Open: $ 15.80   Volume: 720
High: $ 15.80   Yield(%) 0.26
Low: $ 15.80   P/E Ratio (ttm): 53.97
Dividend ($): 0.04   Market Cap ($): 15.59B
EPS ($) 0.30   Shares Out: 973.15M
M = Million B = Billion
Price Performance
% Price Change (last 4 weeks): -17.86
% Price Change (last 13 weeks): -42.40
% Price Change (last 26 weeks): -41.20
% Price Change (last 52 weeks): -35.76
% Price Change (year to date): -39.45
Management Effectiveness
Return on Equity (%): 12.11
Return on Assets (%): 4.79
Return on Invested Capital (%): 19.15
Profitability
Gross Profit Margin (%): 44.44
Net Profit Margin (%): 11.16
Operating Profit Margin (%): 17.46
Price & Volume
50-day Moving Average: $13.09
200-day Moving Average: $12.91
Avg. Daily Vol. (last 50 days): 4,721
Avg. Daily Vol. (last 200 days): 2,939
52-wk high: $31.80
52-wk low: $15.80
Bid: $n/a
Ask: $n/a
Company Information
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The firm offers a broad portfolio of products that focuses on all steps in the manufacture of a biopharmaceutical, as well as in process development as prerequisite procedures. Its technologies cover inter alia, cell line technologies, cell culture media, bioreactors, and a wide range of products for separation, purification, and concentration of biological intermediates and finished products, as well as solutions for storage and transportation. It also offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production. The company was founded on September 28, 1978 and is headquartered in Aubagne, France.
Sartorius Stedim Biotech S.A.
Zone Industrielle Les Paluds Avenue de Jouques
Aubagne PA 13400

Phone: 33.4.42.84.56.00
Fax: 33.4.42.84.56.19
http://www.sartorius.com
Per Share Data
Earnings (1year) ($): 0.30
Annual Dividend ($): 0.04
Current P/E Ratio (ttm): 53.97
Book Value ($): 3.16
Cash Flow ($): 0.64
Valuation Ratios
Price/Earnings (x): 53.97
Price/Sales (x): 8.13
Price/Book (x): 8.37
Price/Cash Flow (x): 35.82
Financial Strength
Quick Ratio (x): 0.57
Current Ratio (x): 1.51
LT Debt/Equity (x): 136.58
Total Debt/Equity (x): 139.58



Quotes displayed with 15 minutes delay. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions. Legal Statement. News provided by MT Newswires, a Division of MidnightTrader, Inc. Events Data provided by Wall Street Horizon. ©2020 Wall Street Horizon, Inc.